Toxins that alter neurotransmitter release from nerve terminals are of considerable scientific and clinical importance. Many advances were recently made in the understanding of their molecular mechanisms of action and use in human therapy. Here, we focus on presynaptic neurotoxins, which are very potent inhibitors of the neurotransmitter release because they are endowed with specific enzymatic activities: (1) clostridial neurotoxins with a metallo-proteolytic activity and (2) snake presynaptic neurotoxins with a phospholipase A2 activity. © 2008 Springer-Verlag Berlin Heidelberg.
CITATION STYLE
Rossetto, O., & Montecucco, C. (2008). Presynaptic neurotoxins with enzymatic activities. Handbook of Experimental Pharmacology, 184, 129–170. https://doi.org/10.1007/978-3-540-74805-2_6
Mendeley helps you to discover research relevant for your work.